ResultsIQ

ResultsIQ › Latest results › Fairchem Organics Limited

Fairchem Organics Limited Q2 FY27 results deck summary

NSE: FAIRCHEMOR · BSE: 543252

Results deck of 22 Oct 2026, summarised by AI from the filing.

Q2 FY27 PAT without exceptional item ₹102 Mn (Q2 FY26: ₹8 Mn, +1175.0%) on revenue from operations ₹1,669 Mn (Q2 FY26: ₹1,115 Mn, +49.7%).

Key takeaways

  1. Q2 profit Q2 FY27 PAT without exceptional item ₹102 Mn (Q2 FY26: ₹8 Mn, +1175.0%) on revenue from operations ₹1,669 Mn (Q2 FY26: ₹1,115 Mn, +49.7%).
  2. Margin recovery H1 FY27 EBITDA margin 10.32% against FY26 full-year 4.70%, on better domestic realisation due to lower imports.
  3. Raw material Cut in crude soya oil import duty from 16.5% to 11.0% is expected to improve raw material availability and capacity utilisation during the year.
  4. Macro risk Management flags uncertain macros due to the middle east crisis despite being consciously optimistic on tariffs and FTAs.

Original filing on BSE

Fairchem Organics Limited Q2 FY27 results

As filed: Revenue ₹167 cr (+49% year on year), EBITDA ₹17.5 cr (+251% year on year), PAT ₹10.2 cr (+300% year on year), EBITDA margin 10.5% (+604 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹176 cr (+34% year on year), EBITDA ₹17.9 cr (+198% year on year), PAT ₹10.0 cr (+300% year on year), EBITDA margin 10.1% (+556 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 556 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −13.3% in 30 days (Nifty 500: +2.8%).
  • Q4 FY26: Revenue ₹117 cr (−3% year on year), EBITDA ₹8.0 cr (+61% year on year), PAT ₹3.7 cr (+269% year on year), EBITDA margin 6.9% (+274 bps). Score 69 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was well above it. EBITDA margin rose 274 bps year on year. Share price after the results: −4.6% in 30 days (Nifty 500: −2.9%).
  • Q3 FY26: Revenue ₹100 cr (−12% year on year), EBITDA ₹4.2 cr (−54% year on year), PAT −₹0.1 cr (−87% year on year), EBITDA margin 4.2% (−373 bps). Score 37 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin fell 373 bps year on year. Revenue fell 11% from last quarter. Share price after the results: −8.4% in 28 days (Nifty 500: −4.1%).
  • Q2 FY26: Revenue ₹112 cr (−19% year on year), EBITDA ₹5.0 cr (−44% year on year), PAT ₹1.0 cr (−75% year on year), EBITDA margin 4.5% (−201 bps). Score 32 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 201 bps year on year. Tax rate 100%. Revenue fell 15% from last quarter. Share price after the results: −6.5% in 28 days (Nifty 500: +1.3%).
  • Q1 FY26: Revenue ₹131 cr (−21% year on year), EBITDA ₹6.0 cr (−74% year on year), PAT ₹1.0 cr (−93% year on year), EBITDA margin 4.6% (−936 bps). Score 26 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 936 bps year on year. Tax rate 0%. Share price after the results: −7.4% in 30 days (Nifty 500: +2.8%).
  • Q4 FY25: Revenue ₹121 cr (−25% year on year), EBITDA ₹5.0 cr (−75% year on year), PAT ₹1.0 cr (−92% year on year), EBITDA margin 4.1% (−829 bps). Score 21 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 829 bps year on year. Tax rate 100%. Profit fell 75% from last quarter. Share price after the results: +12.7% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹114 cr (−23% year on year), EBITDA ₹9.0 cr (−55% year on year), PAT ₹4.0 cr (−67% year on year), EBITDA margin 7.9% (−562 bps). Score 23 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 562 bps year on year. Revenue fell 18% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Fairchem Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.